As you know, early detection helps healthcare professionals deliver timely, appropriate treatment options for patients with Bladder Cancer. The Alere NMP22® BladderChek® Test is designed to aid in the diagnosis and monitoring of Bladder Cancer, and when used in conjunction with other diagnostic procedures, it provides you with the information you need to make treatment decisions as early as possible.
The home testing program involves you at every step:
The patient must contact their physician for a prescription.
The physician writes the prescription and manages the patient’s care.
Alere Home Monitoring always connects the patient to the physician.
Patients are directed to call their physician immediately if they receive a positive test result.
Patients are instructed to continue regularly scheduled physician visits even while testing at home.
For more information about the Alere NMP22® BladderChek® Test for home or in-office use, call 1.866.683.7339.
© 2013 Alere. All rights reserved.